Chest pain, electrocardiogram and cardiac enzimes: a practical proposal for hospital management

Authors

  • Oswaldo Gutiérrez Sotelo Universidad de Costa Rica

DOI:

https://doi.org/10.51481/amc.v61i1.1025

Keywords:

chest pain, coronary thrombosis, cardiac enzymes

Abstract

The clinical presentation of coronary arteriosclerotic disease covers a broad spectrum: from the patient totally asymptomatic, despite the existence of obstructive lesions of variable degree in the coronary tree, or the patient who refers precordial oppression related exclusively to physical activity, even the patient who suffers severe oppressive precordial pain at rest, and goes to the emergency room. In each of these contexts, there is a distinct physiopathological sequence, despite its common origin.

A practical proposal for the management of patients with chest pain in the emergency room, in different clinical contexts with a different pathophysiology is presented. The usefulness and interpretation of the dosage of the ""cardiac enzymes"" is discussed.

Downloads

Download data is not yet available.

References

Libby P. Mechanisms of acute coronary syndromes and their implications for therapy.N Engl J Med 2013;368:2004-13.

Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol 2017;70:1082.

O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2013;82:E1-27.

Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003;349:2128-35.

Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol 2017;70:996-1012.

Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130:2354-94.

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2018. Aug 25. doi: 10.1093/eurheartj/ehy462

Poldervaart JM, Langedijk M, Backus BE, Dekker IMC, Six AJ, Doevendans PA, Hoes AW, Reitsma JB. Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department. Int J Cardiol 2017;227:656-661.

Henderson RA, Jarvis C, Clayton T, Pocock SJ, Fox KA. 10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial. J Am Coll Cardiol 2015;66:511-20.

Hoedemaker NPG, Damman P, Woudstra P, Hirsch A, Windhausen F, Tijssen JGP, de Winter RJ; ICTUS Investigators. Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial. J Am Coll Cardiol 2017;69:1883-1893.

Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011;32:404-11.

McCarthy CP, Vaduganathan M, Januzzi JL Jr. Type 2 Myocardial InfarctionDiagnosis, Prognosis, and Treatment. JAMA 2018;320:433-434.

Januzzi JL Jr. Causes of Non ACS Related Troponin Elevations. American College of Cardiology Set 8, 2010. https://www.acc.org/latest-in-cardiology/ articles/2014/07/18/13/16/causes-of-non-acs-related-troponin-elevations.

Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med 2015;373:610-20.

Published

2019-01-14 — Updated on 2019-01-14

Versions

How to Cite

Chest pain, electrocardiogram and cardiac enzimes: a practical proposal for hospital management. (2019). Acta Médica Costarricense , 61(1), 43-47. https://doi.org/10.51481/amc.v61i1.1025